This latest funding will help Mightier expand its team and scale its proven technology to reach more children who struggle with their emotions. The funds will also help Mightier expand its reach into the healthcare industry through a strategic partnership the company entered with Magellan Health earlier this year.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
